Portfolio Strategy & Delivery Lead

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come.

Join Roche, where every voice matters.

The Position

In Roche’s Pharmaceutical Research and Early Development organisation (pRED), we make transformative medicines for patients to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicines. Together, we create a culture defined by curiosity, responsibility, and humility, where our talented people are empowered and inspired to bring forward extraordinary, life-changing innovation at speed.

Strategy, Portfolio & Operations (SPO) is a unified function that serves as the strategic and operational backbone enabling pRED's strategy from lab to clinic. Operating under a dynamic Chapter Model, SPO centralises specialised skills across critical areas, including Sites & Lab Services, Program & Project Management, Strategy, Clinical Operations, External Operations, Capability Development, Core Lab Technology Platforms (360

Labs) and Asset Team Leadership. SPO’s mission is to drive enterprise value creation by delivering operational excellence and accelerating portfolio productivity. As a trusted partner, SPO fosters a culture of collaboration and accountability to ensure pRED transitions assets smoothly from early research to late-stage development.

At Roche/Genentech Pharma Research and Early Development Clinical Operations (pRED CO), we are determined to transform early drug development and realise our Pharma Ambition to deliver 20 transformative medicines addressing diseases with the highest societal burden by 2029. The pRED Portfolio Strategy & Delivery Lead leads the delivery of one or more of our Discovery & Delivery Areas (DTAs), driving productivity, efficiency and innovation.

This senior people leadership position holds significant accountability for the pRED Clinical Operations strategy and execution, as well as enterprise collaboration.

The Opportunity

The pRED Portfolio Strategy & Delivery Lead is a senior strategic leader and decision‑maker within Roche pRED Clinical Operations and is responsible and accountable for shaping an industry‑leading CO DTA strategy that successfully delivers the pRED portfolio of programs and studies in the assigned DTA(s). Leads the functional area of responsibility (Asset, Study Management, Data & Technology or People), driving the identification and development of new ways of working to push the boundaries of excellence in delivery and engagement continually.

As the DTA Portfolio Strategy & Delivery Lead, you will:

Build, drive, and enhance cross‑functional enterprise collaborations and influence decision‑making across early‑ and late‑stage development, while providing a strong strategic operational voice to remove barriers and align on priorities.

• pRED:
  Partner with Early Development Heads and Project Team Leaders to translate eSPC and DTA strategies into a coherent pRED CO delivery portfolio strategy that balances business needs with budgets and resources. Serve as the primary decision‑maker for prioritising strategic operational DTA decisions, collaborating across early and late‑stage teams to optimise day‑to‑day execution. Additionally, leverage data analytics, informatics, and AI to drive data‑driven decision‑making, while working cross‑functionally with CO leadership to refine delivery strategies, overcome performance challenges, and enhance both operational efficiency and employee engagement.
• PD, gRED and Roche Enterprise:
  As the voice for pRED in your therapeutic area(s) you must proactively identify, develop, and maintain collaborative relationships with senior leaders across the Roche Enterprise to ensure early development representation and influence for the end‑to‑end delivery of the portfolio, including late‑stage…